Laurion Capital Management LP Corcept Therapeutics Inc Transaction History

Laurion Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$16.78 - $27.3 $635,911 - $1.03 Million	-37,897 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$12.46 - $19.98 $472,196 - $757,182	37,897 New	37,897 $660,000
Q2 2018 Aug 13, 2018	SELL	$15.3 - $19.69 $437,488 - $563,015	-28,594 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$14.59 - $25.5 $224,598 - $392,547	15,394 Added 116.62%	28,594 $470,000
Q4 2017 Feb 13, 2018	SELL	$15.77 - $20.72 $500,870 - $658,087	-31,761 Reduced 70.64%	13,200 $238,000
Q3 2017 Nov 13, 2017	BUY	$12.3 - $19.3 $553,020 - $867,747	44,961	44,961 $868,000

347

86.6M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $6.3B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.